Parabilis Medicines (PBLS) director granted 20,215 options at $20.00 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Parabilis Medicines, Inc. director Jake Simson received a stock option grant covering 20,215 shares of common stock. The option has a conversion price of $20.00 per share and expires on June 8, 2036.
The option vests and becomes exercisable in full on the earlier of June 9, 2027 or the date of the company’s next annual stockholder meeting, as long as Simson continues to serve on the board through that vesting date. After this award, he holds 20,215 option-derived shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Simson Jake
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 20,215 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 20,215 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 20,215 shares
Exercise price: $20.00 per share
Shares after transaction: 20,215 shares
+2 more
5 metrics
Option grant size
20,215 shares
Underlying common stock in new option award
Exercise price
$20.00 per share
Conversion or exercise price of the option
Shares after transaction
20,215 shares
Total option-derived shares following the grant
Expiration date
June 8, 2036
Option expiration for this grant
Vesting latest date
June 9, 2027
Latest date when options vest if still serving
Key Terms
Stock Option (Right to Buy), conversion or exercise price, expiration date, vest and become exercisable
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
conversion or exercise price financial
"conversion_or_exercise_price: "20.0000""
expiration date financial
"expiration_date: "2036-06-08T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest and become exercisable financial
"shall vest and become exercisable in full upon the earlier of"
FAQ
What did Parabilis Medicines (PBLS) director Jake Simson report on this Form 4?
Jake Simson reported receiving a grant of stock options covering 20,215 shares of Parabilis Medicines common stock. The award is a compensation-related grant with a $20.00 exercise price, not an open-market purchase or sale of existing PBLS shares.
How many Parabilis Medicines (PBLS) options did Jake Simson receive and at what price?
He received stock options for 20,215 underlying PBLS common shares at a $20.00 per share exercise price. This means he can buy those shares at $20.00 once the options vest and become exercisable, subject to the vesting conditions being met.
When do Jake Simson’s Parabilis Medicines (PBLS) stock options vest?
The options vest in full on the earlier of June 9, 2027 or the date of Parabilis Medicines’ next annual stockholders’ meeting. Vesting requires that Simson continue serving as a director through that vesting date, according to the footnote disclosure.
When do Jake Simson’s Parabilis Medicines (PBLS) options expire?
The stock options expire on June 8, 2036 if not exercised. After that expiration date, Simson would no longer be able to purchase PBLS shares at the $20.00 exercise price provided by this particular grant of options.